Perry Andrew - Insider Non-Derivative Transactions at G1 Therapeutics, Inc. (GTHX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Sep 18, 2024, Perry Andrew's relationship to G1 Therapeutics, Inc. (GTHX) is Officer (Chief Commercial Officer), and currently has 128,714 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other GTHX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Perry Andrew - Insider Non-Derivative Transactions of GTHX Common Stock

Perry Andrew - Insider Non-Derivative Transactions at GTHX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Sep 19, 2024	U -- (Common Stock)	14232	0	0
Sep 19, 2024	Disposition -- (Common Stock)	114482	0	14232
Sep 19, 2024	Acquisition -- (Common Stock)	16100	0	128714
Jul 6, 2024	Sell -- (Common Stock)	1337	2.51	112614
Jul 2, 2024	Acquisition -- (Common Stock)	35000	0	113951
May 14, 2024	Sell -- (Common Stock)	8151	4.79	78951
Jan 4, 2024	Sell -- (Common Stock)	2034	3.12	87102
Jan 4, 2024	Sell -- (Common Stock)	379	3.12	89136
Jan 4, 2024	Acquisition -- (Common Stock)	33570	0	89515
Jul 6, 2023	Sell -- (Common Stock)	355	2.45	55945
May 11, 2023	Acquisition -- (Common Stock)	35000	0	56300
Jan 5, 2023	Sell -- (Common Stock)	820	5.58	21300
Jan 4, 2023	Acquisition -- (Common Stock)	16100	0	22120